https://www.selleckchem.com/products/unc8153.html
77). The median time of support was 351 days (IQR 136-626) for RA HVAD compared to 135 days (IQR 61-244) for RV HVAD (P = .02). Pump thrombosis occurred at a similar rate [RA 3/10 (30.0%) vs. RV 6/20 (30.0%), P = 1], as did GI bleeding [RA 10/35 (28.6%) vs. RV 5/21 (23.8%), P = .94] during the follow-up time period. Kaplan-Meier analysis when censored for transplant showed higher survival with RA HVAD compared to RV HVAD (P = .036), with an estimated survival at 1 year of 91.7% (95% CI 77.3-100. in RA HVAD versus 66.2% (95% CI 48.9-89
Like
Comment
Share
